Oxidative Stress in Obstructive Sleep Apnea: Correlation of Biomarkers and Nasal CPAP Compliance
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01661699|
Recruitment Status : Completed
First Posted : August 9, 2012
Last Update Posted : August 28, 2014
|Condition or disease|
|Sleep Apnea, Obstructive|
|Study Type :||Observational|
|Actual Enrollment :||24 participants|
|Official Title:||Oxidative Stress in Obstructive Sleep Apnea: Correlation of Biomarkers and Nasal CPAP Compliance|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||July 2014|
|Actual Study Completion Date :||July 2014|
Those suspected of sleep apnea and scheduled for polysomnography and treated with CPAP therapy.
- Determining biomarkers for polysomnography characteristics before and after CPAP treatment [ Time Frame: 6 months ]The primary objective of this pilot study will determine the biomarkers for polysomnography characteristics with CPAP treatment from baseline to 6 months in patients with obstructive sleep apnea. The results will guide biomarker selection for full scale studies.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01661699
|United States, District of Columbia|
|Georgetown University Hospital|
|Washington, District of Columbia, United States, 20007|
|Principal Investigator:||Cristina Reichner, MD||Georgetown University|